Carly Kenselaar

Item: Carly Kenselaar
Rating: 2.87
Author: StockAnalysis.com

Stock Analyst at Citigroup

(2.87)

# 1,552

Out of 5,114 analysts

Total ratings

100%

Success rate

97.29%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$240.80	-26.91%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$34.51	-7.27%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $240.80

Upside: -26.91%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $34.51

Upside: -7.27%